25 Dec 2011
Predictions for 2012 with the Stuttering Brain (311)
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | Stitcher | TuneIn | RSS
Dr. Tom Weidig, the brain behind the Stuttering Brain blog, joins Peter Reitzes to discuss his five stuttering predictions for 2012. Dr. Weidig predicts that:
1. A Dutch study (or the findings) due out soon will show no difference between Lidcombe treatment for preschoolers and a Demands and Capacities treatment approach.
2. More input from mainstream scientists on stuttering research relating to genes and biochemistry.
3. More trials on drugs but nothing much happening.
4. Discussions on blogs and podcasts might switch more to social media, especially Facebook.
5. The results from the large long-term Phase IIb trial on Pagoclone will be released. They will show that the control group (who took a placebo pill) show significant improvements. The study of this effect will force us to reconsider all outcome studies ever done and compare them to the control groups’ improvements.
Dr. Weidig also reviews the predictions he made at the very end of 2010 for 2011.
For more information on Lidcombe stuttering treatment, listeners may wish to listen to these StutterTalk podcasts:
26 Mar 2017
No One Has a Crystal Ball (Ep. 615)
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | Stitcher | TuneIn | RSS
Phil Schneider joins Peter Reitzes to discuss the promises and predictions that professionals, such as speech-language pathologists, sometimes make to people who stutter and their families.
Phil Schneider, Ed.D. CCC-SLP is a Board Certified Specialist and Mentor in Fluency and Fluency Disorders and has been working in private practice for 45 years with children and adults who stutter. Dr. Schneider is an Associate Professor Emeritus of Communication Disorders at Queens College and, with Uri Schneider, is creator of the films Transcending Stuttering: The Inside Story and Going with the Flow: A Guide to Transcending Stuttering.